TRCT
NKTX icon

Tower Research Capital (TRC)’s Nkarta NKTX Stock Holding History

Tower Research Capital (TRC)’s Portfolio NKTX Stock Details NKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.7K Buy
8,009
+2,770
+53% +$7.8K ﹤0.01% 3442
2026
Q1 		$11.1K Sell
5,239
-4,219
-45% -$9.44K ﹤0.01% 3859
2025
Q4 		$17.5K Sell
9,458
-2,516
-21% -$5.03K ﹤0.01% 3201
2025
Q3 		$24.8K Sell
11,974
-8,385
-41% -$17.2K ﹤0.01% 3107
2025
Q2 		$33.8K Buy
20,359
+10,073
+98% +$18.5K ﹤0.01% 3313
2025
Q1 		$18.9K Buy
10,286
+3,215
+45% +$6.59K ﹤0.01% 3027
2024
Q4 		$17.6K Buy
7,071
+2,656
+60% +$8.2K ﹤0.01% 3300
2024
Q3 		$20K Buy
4,415
+1,396
+46% +$7.93K ﹤0.01% 3239
2024
Q2 		$17.8K Buy
3,019
+672
+29% +$4.75K ﹤0.01% 3816
2024
Q1 		$25.4K Sell
2,347
-2,293
-49% -$23.8K ﹤0.01% 2790
2023
Q4 		$30.6K Sell
4,640
-6,114
-57% -$15.8K ﹤0.01% 3412
2023
Q3 		$14.9K Buy
10,754
+3,438
+47% +$6.52K ﹤0.01% 3645
2023
Q2 		$16K Buy
7,316
+5,070
+226% +$22.3K ﹤0.01% 3587
2023
Q1 		$8K Sell
2,246
-551
-20% -$2.61K ﹤0.01% 4644
2022
Q4 		$17K Buy
2,797
+1,149
+70% +$11.6K ﹤0.01% 3283
2022
Q3 		$22K Sell
1,648
-5,074
-75% -$72.6K ﹤0.01% 3866
2022
Q2 		$83K Sell
6,722
-7,871
-54% -$103K ﹤0.01% 2437
2022
Q1 		$166K Buy
14,593
+12,918
+771% +$138K ﹤0.01% 1862
2021
Q4 		$26K Sell
1,675
-1,033
-38% -$17.7K ﹤0.01% 3390
2021
Q3 		$75K Buy
2,708
+913
+51% +$28.9K ﹤0.01% 2637
2021
Q2 		$57K Sell
1,795
-230
-11% -$6.63K ﹤0.01% 2915
2021
Q1 		$67K Buy
2,025
+1,617
+396% +$77.3K ﹤0.01% 2883
2020
Q4 		$25K Sell
408
-2,189
-84% -$90.9K ﹤0.01% 3724
2020
Q3 		$78K Buy
+2,597
New +$76.5K ﹤0.01% 3324

Other funds holding NKTX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
GP
GSK plc London $602M AUM
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Tower Research Capital (TRC)'s NKTX Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Nkarta (NKTX) stake by 53% in Q2 2026, buying an estimated $7.8K and bringing the position to 8,009 shares worth $22.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3442.

Tower Research Capital (TRC) first reported a position in NKTX in Q3 2020 and has held it in 24 quarters since. The position peaked at $166K in Q1 2022. 136 funds tracked by Wall St. Rank hold NKTX as of Q2 2026.

  • Tower Research Capital (TRC) held 8,009 shares of Nkarta worth $22.7K as of Q2 2026.
  • Tower Research Capital (TRC) bought 2,770 Nkarta shares in Q2 2026, an estimated $7.8K.
  • Nkarta made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3442 holding.
  • Tower Research Capital (TRC) first reported a position in Nkarta in Q3 2020 and has held it in 24 quarters since.
  • Tower Research Capital (TRC)'s Nkarta position peaked at $166K in Q1 2022.
  • 136 funds tracked by Wall St. Rank held Nkarta as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.